OneSkin raises $20m
- alexandrabibaut
- Jan 23
- 1 min read
The expert brand in skin longevity has secured $20 million (approximately €17.25 m) from Prelude Growth Partners. Founded by a quartet of female scientists, OneSkin focuses on reducing senescent cells with its OS-01 peptide. This investment will support the development of new topical and systemic products, as well as the expansion of the brand's community. Prelude will also contribute its strategic expertise to strengthen OneSkin's positioning in skin longevity.



Comments